Laboratory to licence breast cancer genetic marker
This article was originally published in Clinica
Executive Summary
US government researchers have discovered a molecular marker which they think could be the basis of an early test for breast cancer. The researchers, from the Berkeley Lab in California, are looking to license the marker, called AZ-1, to diagnostics manufacturers.